Skip to Main Content

Good morning, everyone, and how are you today? The sun is trying to peek through the clouds descending this morning on the Pharmalot campus, where our official mascot is lounging about and assorted birds and bugs can be heard in the distance. As for us, we are immersed in our usual routine of foraging for interesting items and brewing cups of stimulation. It is, after all, another busy day. No doubt, it is the same for you. So here are some tidbits to help you along. Hope today proves successful, and keep in touch …

Rejecting sharp criticism from U.S. government scientists, AstraZeneca (AZN) said Wednesday night its vaccine was 76% effective at reducing the risk of symptomatic Covid-19, and 100% effective against severe disease, STAT writes. The new analysis of its large U.S.-based clinical trial shows the new estimates were just a few percentage points lower than much more sparse results released Monday from an earlier analysis, despite dramatic statements from government scientists that the company’s initial release may have used “outdated information” that could have been overly favorable.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!